PRL and ataxia telangiectasia: Another interesting finding is baseline differences between both study populations in most outcome measures: HOMA1-IR, HDL cholesterol, antibody titers, uric acid, hsCRP, fibrinogen, homocysteine, and UACR, suggesting that cardiometabolic risk may be greater if prolactin excess is observed in individuals with AT.